Technical Articles

基于TR-FRET技术的CRBN配体筛选在蛋白质降解剂研发中的应用
Application of CRBN Ligand Screening Based on TR-FRET Technology in the Development of Protein Degraders
发布时间 2026-04-13
Thalidomide is a compound composed of glutarimide and phthalimide, and its derivatives lenalidomide and pomalidomide are collectively known as immunomodulatory imide drugs, primarily used to treat hematologic malignancies such as multiple myeloma.
View details
  • Drug Research
  • TR-FRET Technology
  • CRBN Ligand
  • Protein Degrader
GSPT1蛋白降解剂的研发进展与DDB1-CRBN&GSPT1 PROTAC试剂盒的应用价值
Research Progress on GSPT1 Protein Degraders and the Application Value of DDB1-CRBN&GSPT1 PROTAC Reagent Kits
发布时间 2026-01-22
Targeted protein degradation (TPD) is a promising new direction in anticancer therapy, with molecular glues and PROTAC strategies demonstrating significant potential in inducing the degradation of disease-causing proteins.
View details
  • Cancer
  • DDB1-CRBN&GSPT1 PROTAC Kit
  • Malignant tumor
  • Protein degrader
Total 2
  • 1
Go to